Recruiting

Observational Study

Sponsor:

Duke University

Code:

NCT00512694

Conditions

Systemic Lupus Erythematosus

Cutaneous Lupus

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

Lupus is a systemic autoimmune disease that can present with many varied symptoms, including joint pain, fevers, kidney disease, and rashes. Lupus can affect anyone, but it is most common in younger women.

The Duke Lupus Registry will collect information and blood samples from patients with lupus (systemic lupus erythematosus or cutaneous lupus) seen in the Duke Rheumatology clinics. The goal of this Registry is to understand how lupus changes over time so that we can improve the treatment of patients with lupus.

Conditions

Systemic Lupus Erythematosus

Cutaneous Lupus

Study ID

NCT00512694

Start date

Jul, 2007

Status verified date

Jan, 2026

Completion date

Jun, 2028

Anticipated

Primary completion date

Jun, 2028

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Diagnosis of Systemic Lupus Erythematosus or Cutaneous Lupus
  • Patient of a rheumatologist at Duke University Medical Center

Exclusion Criteria:

  • Inability to travel to Duke for follow-up visits
  • Inability to speak English
  • Not able to provide informed consent

Study Design

Enrollment

1000 participants

Anticipated

Interventions and Outcome Measures

Central Contacts and Locations

Central contacts

Locations

Duke University Medical Center

Recruiting

Durham, North Carolina, United States, 27710

Principal Investigator:

Megan E. B. Clowse, MD, MPH

More Information

Sponsor

Duke University

Last update posted

Jan 8, 2026

Last verified

Jan, 2026

Keywords

  • Lupus
  • Systemic Lupus Erythematosus
  • Cutaneous Lupus

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Duke University on 2026-01-08.